| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6184850 | Gynecologic Oncology | 2015 | 6 Pages |
Abstract
The patient-administered bFHQ effectively identified women with confirmed LS and is a good screening tool to triage women with endometrial cancer for further genetic assessment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Lua Eiriksson, Melyssa Aronson, Blaise Clarke, Golnessa Mojtahedi, Christine Massey, Amit M. Oza, Steven Gallinger, Aaron Pollett, Helen Mackay, Marcus Q. Bernardini, Sarah E. Ferguson,